[Therapy of bronchial carcinoma. Intermittent high-dosage polychemotherapy of bronchial carcinoma in combination with radical surgery for the prevention of recurrences and in primarily inoperable patients].
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001317:Austria; D001984:Bronchial Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D010166:Palliative Care
D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate
Zur Therapie des Brohchuskarzinoms. Intermittierende hochdosierte Polychemotherapie des Bronchuskarzinoms in Kombination mit Radikaloperation zur Rezidivprophylaxe und bei primär inoperablen Patienten.